Simulated microgravity conditions enhance differentiation of cultured PC12 cells towards the neuroendocrine phenotype.
We are studying microenvironmental cues which contribute to neuroendocrine organ assembly and tissue-specific differentiation. As our in vitro model, we cultured rat adrenal medullary PC12 pheochromocytoma cells in a novel cell culture system, the NASA rotating wall vessel (RWV) bioreactors. This "simulated microgravity" environment in RWV bioreactors, characterized by randomizing gravitational vectors and minimizing shear stress, has been shown to favor macroscopic tissue assembly and to induce tissue-specific differentiation. We hypothesized that the unique culture conditions in the RWV bioreactors might enhance the in vitro formation of neuroendocrine organoids. To test our hypothesis, we evaluated the expression of several markers of neuroendocrine differentiation in cultures of PC12 cells maintained for up to 20 d in the slow turning lateral vessel (STLV) type RWV. PC12 cell differentiation was assessed by morphological, immunological, biochemical and molecular techniques. PC12 cells, cultured under "simulated microgravity" conditions, formed macroscopic, tissue-like organoids several millimeters in diameter. Concomitantly, the expression of phenylethanolamine-N-methyl transferase (PNMT), but not of other catecholamine synthesizing enzymes, was enhanced. Increased PNMT expression, as verified on both the gene and protein level, was accompanied by an increase in the specific activity of the enzyme. Furthermore, after 20 d in culture in the STLV, we observed altered patterns of protein tyrosine phosphorylation and prolonged activation of c-fos, a member of the AP-1 nuclear transcription factor complex. We conclude that culture conditions in the RWV appear to selectively activate signal transduction pathways leading to enhanced neuroendocrine differentiation of PC12 cells.
Lelkes
P I
PI
Laboratory of Cell Biology, University of Wisconsin Medical School, Milwaukee Clinical Campus, 53201-0342, USA.
Galvan
D L
DL
Hayman
G T
GT
Goodwin
T J
TJ
Chatman
D Y
DY
Cherian
S
S
Garcia
R M
RM
Unsworth
B R
BR
D000818:Animals; D019149:Bioreactors; D002454:Cell Differentiation; D004296:Dopa Decarboxylase / Q000235:genetics; D004299:Dopamine beta-Hydroxylase / Q000235:genetics; D005947:Glucose / Q000378:metabolism; D016716:PC12 Cells; D010641:Phenotype; D010625:Phenylethanolamine N-Methyltransferase / Q000235:genetics / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics; D018474:Weightlessness Simulation / Q000295:instrumentation*
D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase; D004296:Dopa Decarboxylase; D005947:Glucose